Systematic Review

Published on 28 Feb 2024

Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Mohammad Saeid Rezaee-Zavareh
Naomy Kim
Yee Hui Yeo
Hyunseok Kim
Jeong Min Lee
Claude B. Sirlin
Bachir Taouli
Rola Saouaf
Ashley M. Wachsman
Mazen Noureddin

Frontiers in Oncology

doi 10.3389/fonc.2024.1355454

1,591 views

Case Report

Published on 28 Feb 2024

Adult pancreatoblastoma with atypical histological morphology combined with familial adenomatous polyposis: a rare case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ying-Xia Wang
Su-Su Fan
Xue-Rong Peng
Yu-Shan Zhu
Xuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1346964

817 views

Original Research

Published on 28 Feb 2024

Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ji Won Han
Pil Soo Sung
Jae-Sung Yoo
Hee Sun Cho
Soon Kyu Lee
Hyun Yang
Ji Hoon Kim
Heechul Nam
Hae Lim Lee
Hee Yeon Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1372007

1,253 views

Original Research

Published on 27 Feb 2024

Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tianwei Fu
Yating Bao
Zhihan Zhong
Zhenyu Gao
Taiwei Ye
Chengwu Zhang
Huang Jing
Zunqiang Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1355927

935 views

Correction

Published on 26 Feb 2024

Corrigendum: Review of novel functions and implications of circular RNAs in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zheng Liu
Fangming Yang
Zhun Xiao
Yuexuan Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1380699

388 views

Original Research

Published on 26 Feb 2024

Solid pseudopapillary neoplasm of the pancreas: a retrospective study of 195 cases

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chang Fu
Xiaocong Li
Yongxin Wang
Chuangshi Wang
Hengwei Jin
Kai Liu
Hongji Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1349282

891 views

Review

Published on 21 Feb 2024

LINC01134: a pivotal oncogene with promising predictive maker and therapeutic target in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yutian Yu
Jialing Wang
Qingfa Guo
Hongliang Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1265762

845 views

Review

Published on 21 Feb 2024

Exploring the application and future outlook of Artificial intelligence in pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Guohua Zhao
Xi Chen
Mengying Zhu
Yang Liu
Yue Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1345810

1,791 views
4 citations

Systematic Review

Published on 16 Feb 2024

Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

John Hang Leung
Shyh-Yau Wang
Henry W. C. Leung
Agnes L. F. Chan

Frontiers in Oncology

doi 10.3389/fonc.2024.1344798

2,411 views
2 citations

Original Research

Published on 09 Feb 2024

Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Philipp Berning
Adrian E. Schroer
Rishav Adhikari
Alexander C. Razavi
Francois H. Cornelis
Joseph P. Erinjeri
Stephen B. Solomon
Debkumar Sarkar
Hebert Alberto Vargas
Heiko Schöder

Frontiers in Oncology

doi 10.3389/fonc.2024.1324095

1,076 views

Original Research

Published on 08 Feb 2024

Advanced lung cancer inflammation index predicts overall survival of hepatocellular carcinoma after hepatectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuan-Zhang Wen
Gao-Min Liu
Jia-Peng Liao
Ji-Wei Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1294253

1,062 views
2 citations

Original Research

Published on 08 Feb 2024

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Afsaneh Barzi
Caroline M. Weipert
Carin R. Espenschied
Victoria M. Raymond
Andrea Wang-Gillam
Mohammad Amin Nezami
Eva J. Gordon
Daruka Mahadevan
Kabir Mody

Frontiers in Oncology

doi 10.3389/fonc.2024.1339302

2,055 views
1 citation

Systematic Review

Published on 08 Feb 2024

Prognostic value of venous thromboembolism in patients with advanced pancreatic cancer: a systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kaifeng Su
Ruifeng Duan
Yang Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1331706

905 views
1 citation

Case Report

Published on 07 Feb 2024

Transcatheter arterial chemoembolization of apatinib and camrelizumab (SHR1210) against liver metastasis from hepatic neuroendocrine tumor: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ruobing Qi
Wenhua Yang
Sixian Zhu
Jie Mao
Bei Yang
Anhui Xu
Qiang Fu

Frontiers in Oncology

doi 10.3389/fonc.2024.1278340

998 views

Original Research

Published on 07 Feb 2024

A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Honghai Zhang
Shugui Sheng
Wenying Qiao
Ming Han
Ronghua Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1340286

984 views

Correction

Published on 07 Feb 2024

Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuan Feng
Junjun Yang
Wentao Duan
Yu Cai
Xiaohong Liu
Yong Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1370998

602 views

Navigation group

Articles

Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics

Adult pancreatoblastoma with atypical histological morphology combined with familial adenomatous polyposis: a rare case report

Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study

Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study

Corrigendum: Review of novel functions and implications of circular RNAs in hepatocellular carcinoma

Solid pseudopapillary neoplasm of the pancreas: a retrospective study of 195 cases

LINC01134: a pivotal oncogene with promising predictive maker and therapeutic target in hepatocellular carcinoma

Exploring the application and future outlook of Artificial intelligence in pancreatic cancer

Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis

Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations

Advanced lung cancer inflammation index predicts overall survival of hepatocellular carcinoma after hepatectomy

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

Prognostic value of venous thromboembolism in patients with advanced pancreatic cancer: a systematic review and meta-analysis

Transcatheter arterial chemoembolization of apatinib and camrelizumab (SHR1210) against liver metastasis from hepatic neuroendocrine tumor: a case report

A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy

Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research